Sarepta Therapeutics, Inc.
SRPT
DELAYED 1 MONTH
22 insider filings · Latest: Jul 28, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Mar 14 12:03 AM | Stephen MayoDirector | Sale | 7,239 | $17.02 | $123.2K | 1,765(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Jul 30 12:05 AM | Michael SeverinoDirector, Chief Executive Officer | Grant/Award | 2,224,342 | $17.74 | 2,224,342(D) | View → |
| Mar 1, 2026 | Mar 4 1:04 AM | Ian Michael EstepanChief Operating Officer | Option Exercise | 8,125 | — | 0(D) | View → |
| Mar 1, 2026 | Mar 4 1:02 AM | Louise Rodino-KlapacPresident, R&D and Tech Ops | Option Exercise | 8,125 | — | 0(D) | View → |